Panel hears final pleas on Glaxo diabetes drug

Panel hears final pleas on Glaxo diabetes drug

posted in: Top News by On July 14th, 2010

GAITHERSBURG, Md (Reuters) – U.S. advisers neared a vote on whether a GlaxoSmithKline Plc diabetes drug carries too much heart risk to stay on the market, hearing final conflicting pleas Wednesday from a patient and a public health advocate.



Original post here Reuters: Top News

For hot penny stock picks, daily small cap alerts, and stock market news alerts visit http://www.stockorange.com

Comments are closed.